Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Astex Pharma Shares Jump After Announcement of Early Results for Leukemia Treatment

By Pharmaceutical Processing | August 28, 2013

Shares of Astex Pharmaceuticals Inc. jumped in premarket trading Wednesday after the drug developer announced early results from a mid-stage study of a possible leukemia treatment.

The Dublin, Calif., company said its potential treatment, labeled SGI-110, achieved an overall complete remission rate of 25 percent when studied in a group of patients with a form of acute myeloid leukemia, a rapidly growing bone marrow cancer.

Astex plans to present more details from its research at an American Society of Hematology meeting in December.

The drug developer, which focuses on cancer treatments, is studying SGI-110 in patients with acute myeloid leukemia and myelodysplastic syndromes. Those are conditions in which blood-forming cells in the bone marrow are damaged.

This can progress to acute myeloid leukemia in many patients, according to the American Cancer Society.

The company’s shares climbed 15.5 percent, or 85 cents, to $6.33 in premarket trading about an hour before the market opening. The stock price has ranged between $2.14 and $6.95 over the past year.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE